NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 52 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $10,992,000 | -3.9% | 8,387,000 | -8.2% | 0.00% | 0.0% |
Q4 2021 | $11,439,000 | -22.9% | 9,137,000 | -17.2% | 0.00% | 0.0% |
Q3 2021 | $14,839,000 | +15.7% | 11,037,000 | +14.5% | 0.00% | 0.0% |
Q2 2021 | $12,824,000 | -2.1% | 9,637,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $13,095,000 | -30.6% | 9,637,000 | -28.8% | 0.00% | 0.0% |
Q4 2020 | $18,873,000 | +7.2% | 13,537,000 | +6.7% | 0.00% | 0.0% |
Q3 2020 | $17,599,000 | -23.1% | 12,687,000 | -8.0% | 0.00% | -50.0% |
Q2 2020 | $22,898,000 | +26.7% | 13,787,000 | -2.0% | 0.00% | 0.0% |
Q1 2020 | $18,075,000 | -24.7% | 14,070,000 | -10.0% | 0.00% | 0.0% |
Q4 2019 | $23,989,000 | +7.3% | 15,625,000 | -3.7% | 0.00% | 0.0% |
Q3 2019 | $22,353,000 | +6.8% | 16,225,000 | +2.5% | 0.00% | 0.0% |
Q2 2019 | $20,923,000 | +0.3% | 15,825,000 | +3.3% | 0.00% | 0.0% |
Q1 2019 | $20,870,000 | +20.5% | 15,325,000 | +3.7% | 0.00% | 0.0% |
Q4 2018 | $17,313,000 | -45.5% | 14,775,000 | -19.8% | 0.00% | 0.0% |
Q3 2018 | $31,754,000 | +34.1% | 18,425,000 | +12.9% | 0.00% | 0.0% |
Q2 2018 | $23,674,000 | – | 16,325,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aequim Alternative Investments LP | 24,000,000 | $30,877,000 | 5.11% |
Alken Asset Management Ltd | 360,000 | $457,000 | 1.90% |
III Capital Management | 3,500,000 | $4,481,000 | 1.64% |
SHENKMAN CAPITAL MANAGEMENT INC | 3,920,000 | $5,113,000 | 0.76% |
CSS LLC/IL | 6,842,000 | $8,745,000 | 0.69% |
DeepCurrents Investment Group LLC | 10,408,000 | $13,373,000 | 0.65% |
SSI INVESTMENT MANAGEMENT LLC | 4,334,000 | $5,554,000 | 0.49% |
WOLVERINE ASSET MANAGEMENT LLC | 18,250,000 | $23,476,000 | 0.34% |
MACKAY SHIELDS LLC | 24,612,000 | $31,641,000 | 0.29% |
Nicholas Investment Partners, LP | 1,115,000 | $1,429,000 | 0.28% |